{"version":"1.0","provider_name":"bip4ex","provider_url":"https:\/\/helloproject.es\/vigilancia","author_name":"Luis Miguel Mej\u00edas Ramos","author_url":"https:\/\/helloproject.es\/vigilancia\/author\/luismi\/","title":"Epigen\u00e9tica e inmunoevasi\u00f3n en CMTN HER2 bajo","type":"rich","width":600,"height":338,"html":"<blockquote class=\"wp-embedded-content\" data-secret=\"AO9WxfdIEu\"><a href=\"https:\/\/helloproject.es\/vigilancia\/epigenetica-e-inmunoevasion-en-cmtn-her2-bajo\/\">Epigen\u00e9tica e inmunoevasi\u00f3n en CMTN HER2 bajo<\/a><\/blockquote><iframe sandbox=\"allow-scripts\" security=\"restricted\" src=\"https:\/\/helloproject.es\/vigilancia\/epigenetica-e-inmunoevasion-en-cmtn-her2-bajo\/embed\/#?secret=AO9WxfdIEu\" width=\"600\" height=\"338\" title=\"\u00abEpigen\u00e9tica e inmunoevasi\u00f3n en CMTN HER2 bajo\u00bb \u2014 bip4ex\" data-secret=\"AO9WxfdIEu\" frameborder=\"0\" marginwidth=\"0\" marginheight=\"0\" scrolling=\"no\" class=\"wp-embedded-content\"><\/iframe><script>\n\/*! This file is auto-generated *\/\n!function(d,l){\"use strict\";l.querySelector&&d.addEventListener&&\"undefined\"!=typeof URL&&(d.wp=d.wp||{},d.wp.receiveEmbedMessage||(d.wp.receiveEmbedMessage=function(e){var t=e.data;if((t||t.secret||t.message||t.value)&&!\/[^a-zA-Z0-9]\/.test(t.secret)){for(var s,r,n,a=l.querySelectorAll('iframe[data-secret=\"'+t.secret+'\"]'),o=l.querySelectorAll('blockquote[data-secret=\"'+t.secret+'\"]'),c=new RegExp(\"^https?:$\",\"i\"),i=0;i<o.length;i++)o[i].style.display=\"none\";for(i=0;i<a.length;i++)s=a[i],e.source===s.contentWindow&&(s.removeAttribute(\"style\"),\"height\"===t.message?(1e3<(r=parseInt(t.value,10))?r=1e3:~~r<200&&(r=200),s.height=r):\"link\"===t.message&&(r=new URL(s.getAttribute(\"src\")),n=new URL(t.value),c.test(n.protocol))&&n.host===r.host&&l.activeElement===s&&(d.top.location.href=t.value))}},d.addEventListener(\"message\",d.wp.receiveEmbedMessage,!1),l.addEventListener(\"DOMContentLoaded\",function(){for(var e,t,s=l.querySelectorAll(\"iframe.wp-embedded-content\"),r=0;r<s.length;r++)(t=(e=s[r]).getAttribute(\"data-secret\"))||(t=Math.random().toString(36).substring(2,12),e.src+=\"#?secret=\"+t,e.setAttribute(\"data-secret\",t)),e.contentWindow.postMessage({message:\"ready\",secret:t},\"*\")},!1)))}(window,document);\n\/\/# sourceURL=https:\/\/helloproject.es\/vigilancia\/wp-includes\/js\/wp-embed.min.js\n<\/script>\n","description":"El Laboratorio de Epigen\u00e9tica del C\u00e1ncer del\u00a0Instituto de Investigaci\u00f3n Sanitaria Illes Balears (IdISBa) ha participado en la publicaci\u00f3n de un estudio en el que se analizan los determinantes epigen\u00e9ticos de un fenotipo inmunoevasivo en el c\u00e1ncer de mama triple negativo HER2 bajo.","thumbnail_url":"https:\/\/www.infosalut.com\/images\/noticies\/cc\/cc-epr1029.jpg"}